Related Experiment Video
Updated: Aug 7, 2026
09:53
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
3.8K
Nasal chondromesenchymal hamartoma: an update
T F C Saunders1, H Bruijnzeel2,3, S Ahmed4
1Department of Otolaryngology, Birmingham Children's Hospital, UK.
The Journal of Laryngology and Otology
|August 23, 2021
Summary
Nasal chondromesenchymal hamartoma is a rare condition presenting with nasal and ocular symptoms. This review of 56 cases and literature highlights the need for multi-specialty treatment and ENT surgeon involvement.
Area of Science:
- Otorhinolaryngology
- Pathology
- Ophthalmology
Background:
- Nasal chondromesenchymal hamartoma (NCH) is a rare benign tumor.
- NCH can manifest with diverse symptoms, affecting ENT, maxillofacial, and ophthalmology services.
Purpose of the Study:
- To conduct a comprehensive literature review of NCH.
- To add three new cases to the existing body of literature.
- To enhance understanding of NCH presentation, associations, and management.
Main Methods:
- Systematic review of the world literature on NCH.
- Inclusion of three newly reported cases.
- Analysis of patient demographics, symptoms, and treatment modalities.
Main Results:
- A total of 56 patients with NCH were identified.
- Patients ranged from pediatric to adult age groups.
- Nasal and ocular symptoms were the most prevalent clinical findings.
- Surgical resection emerged as the primary treatment approach.
Conclusions:
- Increased awareness of NCH and its associated conditions is crucial.
- Multidisciplinary collaboration is essential for optimal patient management.
- The role of the ENT surgeon in the diagnosis and treatment of NCH is significant.
